This inventor holds 1 USPTO granted patent. Top assignee: Oklahoma Medical Research Foundation. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Craig David Shimasaki: Innovator in Viral Detection
Introduction
Craig David Shimasaki is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of viral detection through his innovative work. His research focuses on developing methods to identify influenza viruses, which are crucial for public health.
Latest Patents
Shimasaki holds a patent for "4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for chromogenic and fluorogenic 4,7-dialkoxy-N-acetylneuraminic acid substrates." This patent, which is one of his 1 patent, provides substrates that can detect influenza types A and B in clinical samples. The substrates can distinguish between various viruses that exhibit neuraminidase reactivity, allowing for accurate identification of influenza viruses compared to other viruses such as parainfluenza and mumps.
Career Highlights
Shimasaki is affiliated with the Oklahoma Medical Research Foundation, where he conducts his research. His work has been instrumental in advancing diagnostic methods for influenza, contributing to better healthcare outcomes.
Collaborations
Some of his notable coworkers include Joyce Anne Hansjergen and Avraham Liav. Their collaborative efforts have further enhanced the research and development of viral detection methods.
Conclusion
Craig David Shimasaki's innovative contributions to viral detection highlight the importance of research in public health. His work continues to impact the field positively, providing essential tools for diagnosing influenza viruses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile